High CerS5 expression levels associate with reduced patient survival and transition from apoptotic to autophagy signalling pathways in colorectal cancer
Open Access
- 13 November 2014
- journal article
- research article
- Published by Wiley in The Journal of Pathology: Clinical Research
- Vol. 1 (1) , 54-65
Abstract
Ceramide synthase 5 is involved in the de novo synthesis of ceramide, a sphingolipid involved in cell death and proliferation. In this study, we investigated the role of ceramide synthase 5 in colorectal cancer by examining ceramide synthase 5 expression, clinico‐pathological parameters and association with survival/death signalling pathways in cancer. Immunohistochemical analysis of CerS5 was performed on 102 colorectal cancer samples using tissue microarrays constructed from formalin‐fixed and paraffin‐embedded tissues. We found strong membranous ceramide synthase 5 staining in 57 of 102 (56%) colorectal cancers. A multivariate Cox regression analysis of ceramide synthase 5 expression adjusted for disease stage, differentiation and lymphovascular invasion revealed reduced 5‐year overall survival (p = 0.001) and 5‐year recurrence‐free survival (p = 0.002), with hazard ratios of 4.712 and 4.322, respectively. The effect of ceramide synthase 5 expression on tumourigenic processes was further characterised by reverse phase protein array analysis. Reverse phase protein arrays were generated from laser capture microdissection‐enriched carcinoma cells from 19 fresh‐frozen colorectal cancer tissues. Measurements of phosphorylation and total levels of signalling proteins involved in apoptosis, autophagy and other cancer‐related pathways revealed two distinct signalling networks; weak membranous ceramide synthase 5 intensity was associated with a proteomic network dominated by signalling proteins linked to apoptosis, whereas strong ceramide synthase 5 intensity was associated with a proteomic sub‐network mostly composed of proteins linked to autophagy. In conclusion, high ceramide synthase 5 expression was found in colorectal cancer tissue and was associated with poorer patient outcomes. Our findings suggest that this may be mediated by a transition from apoptotic to autophagy signalling pathways in ceramide synthase 5 High expressing tumours, thus implicating ceramide synthase 5 in the progression of colorectal cancer.Keywords
Funding Information
- Irish Cancer Society (CRF10KIJ)
- Science Foundation Ireland (10/CE/B1821)
- Pathological Society of Great Britain and Ireland (VF 2013/04/01)
This publication has 40 references indexed in Scilit:
- Ceramide-orchestrated signalling in cancer cellsNature Reviews Cancer, 2012
- Ceramide synthases at the centre of sphingolipid metabolism and biologyBiochemical Journal, 2012
- Alteration of Ceramide Synthase 6/C16-Ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis via Perturbation of Cellular Ca2+ and ER/Golgi Membrane NetworkJournal of Biological Chemistry, 2011
- Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 β-cellsBiochemical Journal, 2011
- Ceramide Synthase-dependent Ceramide Generation and Programmed Cell DeathJournal of Biological Chemistry, 2011
- Mammalian ceramide synthasesIUBMB Life, 2010
- Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancerClimacteric, 2009
- Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancerGut, 2009
- Antiapoptotic roles of ceramide‐synthase‐6‐generated C 16 ‐ceramide via selective regulation of the ATF6/ CHOP arm of ER‐stress‐response pathwaysThe FASEB Journal, 2009
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995